Literature DB >> 11396134

Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study.

E Małusecka1, A Zborek, S Krzyzowska-Gruca, Z Krawczyk.   

Abstract

The present study was undertaken to determine the expression pattern of the hsp70 and the hsp27 genes in 106 cases of non-small cell lung carcinoma (NSCLC). We have shown that in the majority of cases (95/106) the HSP70 immunoreactivity was localized both in the cytoplasm and the nuclei. We also observed an enhanced nuclear immunoreaction for HSP70 in dysplastic lesions and in stage I tumors. In the case of the HSP27 we found a positive cytoplasmic immunostaining in 70% of cases, with the highest score in squamous cell carcinoma (SCC). We noted a positive correlation between the expression level of HSP27 and HSP70. There was a correlation between Ki-67 proliferation index and nuclear HSP70 staining, but not for HSP27. No association between the HSPs and the expression of pRb p16 and p21WAF1/CIP1 and p53 was found as studied previously. An interesting and statistically significant relationship was found between the expression of cyclin D1 and high intensity of HSP27 and HSP70 immunostaining. The relation of our results concerning the expression pattern of the HSP70 and HSP27 in NSCLC to those obtained by others for different types of primary tumors is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396134

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

Review 1.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

2.  Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell lung cancer cells.

Authors:  Z Ju; M Kapoor; K Newton; K Cheon; A Ramaswamy; R Lotan; L C Strong; J S Koo
Journal:  Mol Genet Genomics       Date:  2005-10-11       Impact factor: 3.291

3.  The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma.

Authors:  Timothy G Whitsett; Landon J Inge; Nhan L Tran
Journal:  Transl Lung Cancer Res       Date:  2013-12

Review 4.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.

Authors:  Daniel R Ciocca; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

Review 5.  The HSP70 family and cancer.

Authors:  Maureen E Murphy
Journal:  Carcinogenesis       Date:  2013-04-04       Impact factor: 4.944

6.  Expressions of HSP70 and HSP27 in hepatocellular carcinoma.

Authors:  Mee Joo; Je G Chi; Hyucksang Lee
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

7.  Proteomic analysis of HEK293 cells expressing non small cell lung carcinoma associated epidermal growth factor receptor variants reveals induction of heat shock response.

Authors:  Arpana Kamath; Ann M Joseph; Kumud Gupta; Digamber Behera; Anand Jaiswal; Ravindra Dewan; Maitreyi S Rajala
Journal:  Exp Hematol Oncol       Date:  2015-06-12

8.  Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.

Authors:  Yang Guo; Andreas Ziesch; Sandra Hocke; Eric Kampmann; Stephanie Ochs; Enrico N De Toni; Burkhard Göke; Eike Gallmeier
Journal:  J Cell Mol Med       Date:  2014-10-21       Impact factor: 5.310

9.  Heat shock protein 70 downregulation inhibits proliferation, migration and tumorigenicity in hepatocellular carcinoma cells.

Authors:  Ju Xiong; Xue-Mei Jiang; Shan-Shan Mao; Xiang-Nan Yu; Xiao-Xi Huang
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

Review 10.  The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.

Authors:  Mitsuru Okuno; Seiji Adachi; Osamu Kozawa; Masahito Shimizu; Ichiro Yasuda
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.